Kazuomi Kario Selected Research

Amlodipine (Norvasc)

1/2018	Association Between Change in Central Nocturnal Blood Pressure and Urine Albumin-Creatinine Ratio by a Valsartan/Amlodipine Combination: A CPET Study.
12/2017	Comparison of morning vs bedtime administration of the combination of valsartan/amlodipine on nocturnal brachial and central blood pressure in patients with hypertension.
4/2015	Age-related difference in the sleep pressure-lowering effect between an angiotensin II receptor blocker and a calcium channel blocker in Asian hypertensives: the ACS1 Study.
6/2014	Rationale, study design, and implementation of the ACS1 study: effect of azilsartan on circadian and sleep blood pressure as compared with amlodipine.
1/2013	Titration of amlodipine to higher doses: a comparison of Asian and Western experience.
4/2011	Use of dihydropyridine calcium channel blockers in the management of hypertension in Eastern Asians: a scientific statement from the Asian Pacific Heart Association.
1/2011	Design and rationale of the study of assessment for kidney function by urinary microalbumin in randomized (SAKURA) trial.
5/2008	Effects of strict blood pressure control by a long-acting calcium channel blocker on brain natriuretic peptide and urinary albumin excretion rate in Japanese hypertensive patients.
6/2007	Effects of new calcium channel blocker, azelnidipine, and amlodipine on baroreflex sensitivity and ambulatory blood pressure.
8/2005	Smoking and antihypertensive medication: interaction between blood pressure reduction and arterial stiffness.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kazuomi Kario Research Topics

Disease

182	Hypertension (High Blood Pressure) 10/2022 - 05/2002
63	Stroke (Strokes) 06/2022 - 01/2002
40	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 10/2002
23	Heart Failure 11/2022 - 07/2008
16	Essential Hypertension 10/2022 - 05/2002
15	Masked Hypertension 01/2021 - 04/2007
15	Atrial Fibrillation 01/2021 - 01/2011
14	Type 2 Diabetes Mellitus (MODY) 01/2021 - 04/2004
14	Diabetes Mellitus 01/2019 - 10/2004
13	Cerebral Hemorrhage 12/2015 - 09/2009
11	Atherosclerosis 04/2022 - 10/2004
11	Chronic Renal Insufficiency 01/2021 - 04/2007
10	Sleep Apnea Syndromes (Sleep Apnea) 01/2022 - 09/2006
10	Myocardial Infarction 01/2021 - 01/2010
10	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020 - 11/2009
10	Inflammation (Inflammations) 01/2016 - 03/2007
9	Hypoxia (Hypoxemia) 01/2021 - 11/2005
9	Ischemic Stroke 01/2020 - 02/2004
9	Cerebral Infarction 06/2012 - 10/2003
8	Hyperuricemia 04/2022 - 11/2019
8	Acute Coronary Syndrome 11/2021 - 01/2005
8	Body Weight (Weight, Body) 01/2021 - 05/2010
8	White Coat Hypertension 01/2020 - 01/2007
8	Obesity 01/2019 - 06/2008
7	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2022 - 10/2004
6	Apnea 01/2022 - 09/2006
6	Obstructive Sleep Apnea 01/2022 - 01/2016
6	Cognitive Dysfunction 11/2018 - 07/2008
6	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2018 - 04/2010
6	Isolated Systolic Hypertension 01/2018 - 01/2015
5	Thrombosis (Thrombus) 01/2021 - 04/2017
5	Tachycardia (Tachyarrhythmias) 01/2020 - 12/2005
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019 - 05/2007
5	Cerebrovascular Disorders (Cerebrovascular Occlusion) 11/2018 - 07/2002
5	Insulin Resistance 07/2011 - 01/2007
4	COVID-19 10/2022 - 01/2020
4	Carotid Artery Diseases 04/2022 - 01/2012
4	Cardiac Arrhythmias (Arrythmia) 11/2020 - 07/2010
4	Dementia (Dementias) 01/2020 - 02/2010
4	Hyperlipidemias (Hyperlipidemia) 01/2019 - 10/2004
4	Transient Ischemic Attack 01/2019 - 08/2015
4	Albuminuria 11/2013 - 06/2006
3	Coronary Disease (Coronary Heart Disease) 01/2022 - 04/2011
3	Heart Diseases (Heart Disease) 01/2022 - 12/2005
3	Hematoma 04/2021 - 12/2012

Drug/Important Bio-Agent (IBA)

80	Antihypertensive Agents (Antihypertensives)IBA 01/2022 - 01/2002
21	SaltsIBA 06/2022 - 11/2008
17	Biomarkers (Surrogate Marker)IBA 12/2021 - 01/2007
16	4- (2- (4- hydroxybenzyl)- phenoxy)- N- methylbutylamineIBA 01/2022 - 05/2015
14	Pharmaceutical PreparationsIBA 08/2022 - 04/2011
12	olmesartanIBA 01/2022 - 04/2011
12	salicylhydroxamic acid (SHAM)IBA 01/2022 - 01/2016
12	Angiotensin Receptor AntagonistsIBA 01/2021 - 04/2009
12	Tissue Plasminogen Activator (Alteplase)FDA Link 10/2013 - 06/2008
12	C-Reactive ProteinIBA 06/2013 - 03/2007
11	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2022 - 01/2008
11	Glucose (Dextrose)FDA LinkGeneric 11/2018 - 01/2007
11	Amlodipine (Norvasc)FDA LinkGeneric 01/2018 - 05/2002
10	Neprilysin (Neutral Endopeptidase)IBA 01/2022 - 02/2014
10	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2022 - 02/2014
10	DiureticsIBA 01/2021 - 06/2010
9	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2022 - 02/2014
8	Uric Acid (Urate)IBA 01/2022 - 03/2017
8	Oxygen (Dioxygen)IBA 01/2022 - 11/2005
8	AnticoagulantsIBA 01/2021 - 01/2012
8	cilnidipineIBA 01/2021 - 12/2005
8	Warfarin (Coumadin)FDA LinkGeneric 01/2019 - 01/2012
7	pro-brain natriuretic peptide (1-76)IBA 11/2022 - 05/2014
7	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2021 - 01/2016
7	Valsartan (Vals)FDA Link 01/2021 - 05/2007
7	AlbuminsIBA 01/2021 - 06/2008
7	CalciumIBA 01/2021 - 05/2002
7	omega-Chloroacetophenone (Mace)IBA 11/2020 - 01/2012
6	Febuxostat FDA Link 04/2022 - 01/2020
6	CholesterolIBA 01/2022 - 06/2006
6	CreatinineIBA 01/2021 - 08/2010
6	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2020 - 05/2002
6	Doxazosin (Cardura)FDA LinkGeneric 01/2017 - 08/2004
6	Indicators and Reagents (Reagents)IBA 01/2016 - 10/2003
5	SodiumIBA 01/2022 - 08/2008
5	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2020 - 05/2002
5	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2016 - 06/2002
5	Hemostatics (Antihemorrhagics)IBA 04/2015 - 10/2004
5	azelnidipineIBA 03/2013 - 06/2007
4	AldosteroneIBA 08/2022 - 01/2007
4	antineoplaston A10 (A 10)IBA 06/2022 - 12/2003
4	N-Type Calcium Channels (N-Type Calcium Channel)IBA 01/2021 - 12/2005
4	candesartanIBA 06/2014 - 10/2002
4	Adrenergic Agents (Adrenergic Drugs)IBA 12/2013 - 07/2002
4	Insulin (Novolin)FDA Link 06/2010 - 06/2006
3	Angiotensin IIIBA 01/2022 - 10/2002
3	Troponin T (Troponin T1)IBA 12/2021 - 05/2013

Therapy/Procedure

63	Therapeutics 10/2022 - 09/2002
34	Denervation 01/2022 - 06/2013
10	Catheters 01/2022 - 01/2016
10	Percutaneous Coronary Intervention 09/2021 - 01/2012
6	Drug Therapy (Chemotherapy) 01/2022 - 09/2011
6	Stents 04/2021 - 01/2012
4	Continuous Positive Airway Pressure 01/2022 - 07/2014
3	Blood Pressure Monitors 01/2021 - 12/2016